cyclic mastalgia. Mastodynia
Conditions
Interventions
Intervention 1: first intervention:
flaxseed powder-15 g oral- twice daily(30 g)- for 2 menstrual cycle with water, juice, milk, soup, salad, yoghurt. Intervention 2: intervention 2:
1000 mg evevning
Treatment - Drugs
first intervention:
flaxseed powder-15 g oral- twice daily(30 g)- for 2 menstrual cycle with water, juice, milk, soup, salad, yoghurt
intervention 2:
1000 mg evevning primrose oil- oral capsul- twice daily for 2 menstrual cycle with 1 glass of water
intervention 3:
vitamin E- oral capsul 400 IU- once a day for 2 menstrual cycle with one glass of water
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: cyclical mastalgia for 5 days or more in luteal phase for 2 menstrual cycle; mastalgia intensity of 4 or above based on visual analogue scale in the last cycle; aged 18 to 45 years; having literacy to read and write; living in Mashhad; Informed consent; body mass index between19-29; not taking any drugs for mastalgia in the last 3 month; regular menstrual cycles between 21 and 35 days; Lack of any cases of abnormality in clinical breast examination; not having the history of breast cancer or any kind of breast tumor in the person or first degree relatives like mother or sister; not being willing to get pregnant until the end of the study; not being in the lactation period; having no history of any kind of tumor and cancer in other organs; not being on a specific diet; having no history of any systemic and psychological diseases; lack of a history of breast surgery and injection gel; lack of constipation exclusion criteria:pregnancy; taking any hormonal drugs like contraception pills; experiencing unexpected eventsduring studt; starting any kind of new lifestyle; having allergy or intolerance of supplements or side effects of drugs during study; disruption of eating flaxseed powder or capsuls tor frequent 3 days or constant 5 days; relinquishment to complete the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of cyclic breast pain. Timepoint: at the begining of the study- at the end of first cycle of intervention- at the end of the second sycle of intervention. Method of measurement: visual analog scale.;Duration of the breast pain. Timepoint: at the begining of the study- at the end of first cycle of intervention- at the end of the second sycle of intervention. Method of measurement: number of days in the related form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzane Jafar Nejad
Mashhad University of Medical Sciences
Outcome results
None listed